RELEASE OF EXTRINSIC PATHWAY INHIBITOR AFTER HEPARIN INJECTION - INCREASED RESPONSE IN CANCER-PATIENTS

被引：55

作者：

LINDAHL, AK

ABILDGAARD, U

STOKKE, G

机构：

[1] Hematological Research Laboratory, Aker Hospital, University of Oslo

来源：

THROMBOSIS RESEARCH | 1990年 / 59卷 / 03期

关键词：

cancer; Extrinsic pathway inhibitor; heparin;

D O I：

10.1016/0049-3848(90)90423-A

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：651 / 656

页数：6

共 9 条

[1] ISOLATION OF THE TISSUE FACTOR INHIBITOR PRODUCED BY HEPG2 HEPATOMA-CELLS [J].

BROZE, GJ ;

MILETICH, JP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (07) :1886-1890

[2]

HELLAND IB, 1989, THROMB HAEMOSTASIS, V62, P138

[3]

HOLMER E, 1985, THROMB HAEMOSTASIS, V54, P29

[4]

LINDAHL AK, 1989, ACTA CHIR SCAND, V155, P389

[5]

NORDFANG O, 1990, UNPUB PURIFICATION C

[6]

SANDSET PM, 1989, HAEMOSTASIS, V19, P189

[7] A SENSITIVE ASSAY OF EXTRINSIC COAGULATION PATHWAY INHIBITOR (EPI) IN PLASMA AND PLASMA FRACTIONS [J].

SANDSET, PM ;

ABILDGAARD, U ;

PETTERSEN, M .

THROMBOSIS RESEARCH, 1987, 47 (04) :389-400

[8] HEPARIN INDUCES RELEASE OF EXTRINSIC COAGULATION PATHWAY INHIBITOR (EPI) [J].

SANDSET, PM ;

ABILDGAARD, U ;

LARSEN, ML .

THROMBOSIS RESEARCH, 1988, 50 (06) :803-813

[9]

WARNCRAMER BJ, 1989, THROMB HAEMOSTASIS, V61, P101

← 1 →